Apixaban and Cefdinir drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Apixaban (apixaban) and Cefdinir (cefdinir). Common drug interactions include dehydration among females and pneumonia among males.

The phase IV clinical study analyzes what interactions people have when they take Apixaban and Cefdinir. It is created by eHealthMe based on reports of 27 people who take the same drugs from the FDA, and is updated regularly.

What is Apixaban?

Apixaban has active ingredients of apixaban. It is often used in blood clots. eHealthMe is studying from 60,351 Apixaban users. Check the latest studies of Apixaban.

What is Cefdinir?

Cefdinir has active ingredients of cefdinir. It is often used in sinusitis. eHealthMe is studying from 9,210 Cefdinir users. Check the latest studies of Cefdinir.



On Jul, 11, 2026

27 people who take Apixaban and Cefdinir together, and have interactions are studied.

Apixaban and Cefdinir drug interactions.

What are the common drug interactions of Apixaban and Cefdinir, by gender? *:

female:

  1. Dehydration (dryness resulting from the removal of water)
  2. Diarrhoea
  3. Pancytopenia (medical condition in which there is a reduction in the number of red and white blood cells, as well as platelets)
  4. Anhedonia (inability to experience pleasure from activities usually found enjoyable)
  5. Anxiety
  6. Clostridium difficile colitis (inflammation of colon by clostridium difficile bacteria infection)
  7. Depression
  8. Emotional distress
  9. Pain
  10. Renal failure (kidney dysfunction)

male:

  1. Pneumonia
  2. Enteritis (inflammation of the small intestine)
  3. Enterococcal infection
  4. Fatigue (feeling of tiredness)
  5. Feeling hot
  6. Flank pain (a distressing sensation experienced around the lower back and the upper abdomen)
  7. Hypoaesthesia (reduced sense of touch or sensation)
  8. Intracardiac thrombus (presence of a circumscribed mass with heart wall)
  9. Muscle spasms (muscle contraction)
  10. Nausea (feeling of having an urge to vomit)

What are the common drug interactions of Apixaban and Cefdinir, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

  1. Depression
  2. Enteritis (inflammation of the small intestine)
  3. Renal failure (kidney dysfunction)
  4. Cardiac ventricular thrombosis (blood clot in ventricle)
  5. Chills (felling of cold)
  6. Dehydration (dryness resulting from the removal of water)
  7. Dizziness
  8. Enterococcal infection
  9. Fatigue (feeling of tiredness)
  10. Feeling hot

60+:

  1. Dysphagia (a condition in which swallowing is difficult or painful)
  2. Death
  3. Pneumonia
  4. Acute respiratory failure
  5. Anaemia (lack of blood)
  6. Dry mouth
  7. Epistaxis (bleed from the nose)
  8. Gastrointestinal haemorrhage (bleeding gastrointestinal tract)
  9. Haemoptysis (blood-stained sputum from the bronchi, larynx, trachea, or lungs)
  10. Platelet disorder

What are the existing conditions these people have? *

  1. Enterocolitis (inflammation of the digestive tract, involving enteritis of the small intestine and colitis of the colon): 5 people, 18.52%
  2. Obstruction: 5 people, 18.52%
  3. Myelodysplastic Syndrome (a group of conditions that occur when the blood-forming cells in the bone marrow are damaged): 5 people, 18.52%
  4. Aortic Thrombosis (formation of a blood clot inside aorta): 5 people, 18.52%
  5. Enteritis (inflammation of the small intestine): 5 people, 18.52%
  6. Pain: 4 people, 14.81%
  7. High Blood Pressure: 4 people, 14.81%
  8. Depression: 4 people, 14.81%
  9. Diabetes: 3 people, 11.11%
  10. Cardiac Disorder: 3 people, 11.11%

* Approximation only. Some reports may have incomplete information.

Do you take Apixaban and Cefdinir?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Apixaban and Cefdinir:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Apixaban:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Cefdinir:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Apixaban and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Cefdinir and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on apixaban and cefdinir (the active ingredients of Apixaban and Cefdinir, respectively), and Apixaban and Cefdinir (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: